home / stock / glpgf / glpgf short
Short Information | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,567 |
Total Actual Volume | 312,570 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 12 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 328 |
Average Short Percentage | 64.05% |
Is there a GLPGF Short Squeeze or Breakout about to happen?
See the GLPGF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2023 | $41.7 | $41.75 | $41.75 | $41.7 | 150 | 150 | 100% |
06-20-2023 | $41.6 | $41.6 | $41.6 | $41.6 | 5,000 | 5,000 | 100% |
03-01-2023 | $37.97 | $37.97 | $37.97 | $37.97 | 125,032 | 32 | 0.03% |
10-05-2021 | $50.65 | $50.65 | $50.65 | $50.65 | 80,031 | 31 | 0.04% |
09-27-2021 | $55 | $55 | $55 | $55 | 5 | 5 | 100% |
09-21-2021 | $53.5 | $54.3 | $54.5 | $53.5 | 133 | 15 | 11.28% |
08-20-2021 | $54.25 | $55.85 | $55.85 | $54.25 | 187 | 45 | 24.06% |
07-23-2021 | $51 | $59.5 | $59.5 | $51 | 1,000 | 500 | 50% |
07-15-2021 | $57.475 | $57.5 | $57.5 | $57.475 | 100,100 | 100 | 0.1% |
06-24-2021 | $69.02 | $69.02 | $69.02 | $69.02 | 100 | 100 | 100% |
05-10-2021 | $70.99 | $71.5 | $71.5 | $70.99 | 160 | 150 | 93.75% |
04-29-2021 | $79 | $79 | $79 | $79 | 93 | 93 | 100% |
04-23-2021 | $81.2598 | $81 | $81.2598 | $81 | 42 | 20 | 47.62% |
04-22-2021 | $82.9 | $82 | $82.9 | $82 | 219 | 22 | 10.05% |
04-19-2021 | $79.5 | $79.5 | $79.5 | $79.5 | 12 | 12 | 100% |
04-12-2021 | $78 | $78 | $78 | $78 | 26 | 26 | 100% |
04-09-2021 | $77.7279 | $78.25 | $78.25 | $77.7279 | 25 | 11 | 44% |
02-23-2021 | $86.5 | $86.5 | $86.5 | $86.5 | 113 | 113 | 100% |
02-22-2021 | $86.5 | $86.5 | $86.5 | $86.5 | 113 | 113 | 100% |
02-12-2021 | $86.1 | $86.1 | $86.1 | $86.1 | 29 | 29 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen, Belgium; 4 April 2024, 22:01 CET – Galapagos NV (Euronext & NASDAQ...
Publication of annual report for financial year 2023 Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board members Extraordinary Shareholders’ Meeting resolutions include approval of renewal of authorize...
Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation. Andrew Dickinson is Gile...